Clinical Trial Update: Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial of Carmustine with O6-Benzylguanine for newly diagnosed glioblastoma multiforme has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• BiCNU (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: WITHDRAWN